secwatch.observer — SEC 8-K summary
======================================

Issuer:     Better Therapeutics, Inc. (—)
CIK:        0001832415
Form:       8-K
Filed at:   2023-04-07T23:59:59+00:00
Accession:  0001193125-23-095329
Event type: other_material
Sentiment:  negative
Materiality: 0.81
Item codes: 1.01, 3.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BTTX raises $6.5M at $0.825/share; receives Nasdaq deficiency notice
--------------------------------------------------------------------

- Private placement of 7.88M shares (~$6.5M gross) at $0.825/share, with officer/director participation; closes ~April 10.
- Loan amendment with Hercules halts amortization payments until Aug 1 (or Nov 1 if benchmarks met) and waives prepayment penalty.
- Nasdaq notified company of stockholders' deficit ($899k) below $2.5M min; must submit compliance plan by May 19, 2023.
- Proceeds plus expense reductions expected to extend runway through potential FDA decision on BT-001.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832415/000119312523095329/0001193125-23-095329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832415/000119312523095329/d473119d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-095329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer